[PETDAG] QoQ Annualized Quarter Result on 31-Dec-2022 [#4]

Announcement Date
22-Feb-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Dec-2022 [#4]
Profit Trend
QoQ- -7.86%
YoY- 46.6%
View:
Show?
Annualized Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 36,631,962 35,115,950 34,581,832 36,748,896 36,333,489 34,238,848 30,473,292 13.04%
PBT 1,394,313 1,568,108 1,635,460 1,135,035 1,191,132 988,416 714,856 56.04%
Tax -350,178 -401,978 -409,984 -347,197 -338,870 -268,888 -233,456 31.00%
NP 1,044,134 1,166,130 1,225,476 787,838 852,261 719,528 481,400 67.47%
-
NP to SH 1,016,353 1,155,096 1,207,352 776,595 842,850 712,346 473,976 66.21%
-
Tax Rate 25.11% 25.63% 25.07% 30.59% 28.45% 27.20% 32.66% -
Total Cost 35,587,828 33,949,820 33,356,356 35,961,058 35,481,228 33,519,320 29,991,892 12.06%
-
Net Worth 5,781,902 5,771,967 5,642,818 5,742,164 5,801,771 5,632,884 5,444,127 4.09%
Dividend
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Div 702,040 655,679 596,072 755,025 476,857 317,905 198,690 131.80%
Div Payout % 69.07% 56.76% 49.37% 97.22% 56.58% 44.63% 41.92% -
Equity
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Net Worth 5,781,902 5,771,967 5,642,818 5,742,164 5,801,771 5,632,884 5,444,127 4.09%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 993,454 0.00%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 2.85% 3.32% 3.54% 2.14% 2.35% 2.10% 1.58% -
ROE 17.58% 20.01% 21.40% 13.52% 14.53% 12.65% 8.71% -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 3,687.33 3,534.73 3,480.97 3,699.10 3,657.29 3,446.45 3,067.41 13.04%
EPS 102.27 116.20 121.60 78.20 84.80 71.80 47.60 66.42%
DPS 70.67 66.00 60.00 76.00 48.00 32.00 20.00 131.81%
NAPS 5.82 5.81 5.68 5.78 5.84 5.67 5.48 4.09%
Adjusted Per Share Value based on latest NOSH - 993,454
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 3,683.59 3,531.15 3,477.44 3,695.35 3,653.58 3,442.95 3,064.30 13.04%
EPS 102.20 116.15 121.41 78.09 84.75 71.63 47.66 66.21%
DPS 70.59 65.93 59.94 75.92 47.95 31.97 19.98 131.79%
NAPS 5.8141 5.8041 5.6742 5.7741 5.8341 5.6642 5.4744 4.09%
Price Multiplier on Financial Quarter End Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 -
Price 22.38 22.20 21.34 23.00 20.02 21.12 20.42 -
P/RPS 0.61 0.63 0.61 0.62 0.55 0.61 0.67 -6.05%
P/EPS 21.88 19.09 17.56 29.42 23.60 29.45 42.80 -36.03%
EY 4.57 5.24 5.69 3.40 4.24 3.40 2.34 56.17%
DY 3.16 2.97 2.81 3.30 2.40 1.52 0.98 118.10%
P/NAPS 3.85 3.82 3.76 3.98 3.43 3.72 3.73 2.13%
Price Multiplier on Announcement Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 23/11/23 28/08/23 22/05/23 22/02/23 25/11/22 24/08/22 26/05/22 -
Price 22.86 21.60 22.40 22.12 22.08 21.94 21.12 -
P/RPS 0.62 0.61 0.64 0.60 0.60 0.64 0.69 -6.87%
P/EPS 22.34 18.58 18.43 28.30 26.03 30.60 44.27 -36.58%
EY 4.48 5.38 5.43 3.53 3.84 3.27 2.26 57.73%
DY 3.09 3.06 2.68 3.44 2.17 1.46 0.95 119.37%
P/NAPS 3.93 3.72 3.94 3.83 3.78 3.87 3.85 1.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment